Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,354.40 +121.18 0.80%
S&P 500 1,667.47 +17.00 1.03%
Nasdaq 3,498.97 +33.72 0.97%
Ticker Volume Price Price Delta
STOXX 50 2,817.99 +11.29 0.40%
FTSE 100 6,723.06 +35.26 0.53%
DAX 8,398.00 +28.13 0.34%
Ticker Volume Price Price Delta
Nikkei 15,138.10 +100.88 0.67%
Hang Seng 23,082.70 +38.44 0.17%
S&P/ASX 200 5,180.77 +15.11 0.29%
  • Exchange: NASDAQ GS
  • Sector: Consumer, Non-cyclical
  • Industry: Biotechnology
  • Sub-Industry: Medical-Biomedical/Gene

Biogen Idec Inc

+ Add to Watchlist

BIIB:US

226.8500 USD 1.1400 0.50%

As of 20:10:00 ET on 05/17/2013.

Snapshot for Biogen Idec Inc (BIIB)

Open: 228.3600 Day's Range: 224.6000 - 228.8600 Volume: 1,243,879
Previous Close: 226.8500 52wk Range: 126.3900 - 231.9900 1-Yr Rtn: +72.40%

Stock Chart for BIIB

No chart data available.
  • BIIB:US 226.5200
  • 1D
  • 1M
  • 1Y
226.8500
Interactive BIIB Chart

Previous Close

Key Statistics for BIIB

Current P/E Ratio (ttm) 36.3664
Estimated P/E(12/2013) 28.5525
Relative P/E vs. SPX 2.2289
Earnings Per Share (USD) (ttm) 6.2379
Est. EPS (USD) (12/2013) 7.9450
Est. PEG Ratio 1.5310
Market Cap (M USD) 53,848.48
Shares Outstanding (M) 237.37
30 Day Average Volume 1,332,102
Price/Book (mrq) 7.3373
Price/Sale (ttm) 9.5425
Dividend Indicated Gross Yield -%
Cash Dividend -
Last Dividend
5 Year Dividend Growth -
Next Earnings Announcement 07/24/2013
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BIIB

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BIIB

Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products addresses diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, Crohn's disease, and psoriasis.

William D Young "Bill"ChairmanGeorge A ScangosChief Executive Officer
Susan H AlexanderExec VP/Chief Legal Ofcr/SecyPaul J ClancyExec VP:Finance/CFO
More Company Profile & Key Executives for BIIB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil